carnitine has been researched along with epirubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bartalucci, S; Cinelli, P; De Leonardis, V; De Scalzi, M; Neri, B | 1 |
| Addison, CL; Delaney, CE; Hopkins, SP | 1 |
3 other study(ies) available for carnitine and epirubicin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens.
Topics: Adult; Breast Neoplasms; Carnitine; Doxorubicin; Echocardiography; Epirubicin; Female; Heart Diseases; Humans; Lung Neoplasms; Male; Middle Aged | 1987 |
Supplementation with l-carnitine does not reduce the efficacy of epirubicin treatment in breast cancer cells.
Topics: Antibiotics, Antineoplastic; Base Sequence; Blotting, Western; Breast Neoplasms; Carnitine; Cell Line, Tumor; DNA Primers; Epirubicin; Humans; Reverse Transcriptase Polymerase Chain Reaction | 2007 |